Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome - PRNewswire
Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome PRNewswire
MUNICH and MENLO PARK, Calif., March 26, 2019 /PRNewswire/ -- Breath Therapeutics, a private company developing advanced inhaled therapeutics in ...
Comments
Post a Comment